Pancreatic cancer
- PMID: 32632383
- PMCID: PMC7063518
- DOI: 10.21037/tgh.2019.12.15
Pancreatic cancer
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
References
-
- Koch-Institut, Z.f.K.i.R. 2018. Available online: https://www.krebsdaten.de/Krebs/SiteGlobals/Forms/Datenbankabfrage/daten...
-
- Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., K. AWMF): S3-Leitlinie Exokrines Pankreaskarzinom, 2013 AWMF, and h.l.d.L.h. Registernummer: 032-010OL. Available online: https://www.awmf.org/leitlinien/detail/ll/032-010OL.html
-
- Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 2017;389:1011-24. 10.1016/S0140-6736(16)32409-6 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources